NOVADIP Biosciences S.A. Alternatives & Competitors
12 companies similar to NOVADIP Biosciences S.A. — Novadip is transforming the lives of patients using its unique 3M³ tissue regene...
Indigo
Committed to lighting up the lives of millions of people living with chronic disease.
Zwijnaarde, Belgium
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Marker Therapeutics, Inc.
Pioneering a Multi-Antigen Approach
Houston, United States
Xeno Biosciences
Gastric Bypass in a Pill
Cambridge, United States
Track all NOVADIP Biosciences S.A. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Be Biopharma
Engineered B cells as medicines
Cambridge, United States
Osteoboost Health
First and only FDA-approved non-pharmacological prescription treatment for low bone densit...
San Francisco, United Sta...
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Cambridge, United States
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
San Diego, United States
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
NGM Biopharmaceuticals
Explorers on the frontier of life-changing science.
South San Francisco, Unit...
About NOVADIP Biosciences S.A.
Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration technology platform.
Development of regenerative tissue products, Accelerating healing for bone defects, Regenerative solutions for spine fusion
Patients with large bone defects, Individuals with spinal problems, Young patients with congenital conditions, Healthcare providers, Medical practitioners
Tissue Regeneration, Regenerative Medicine, Biopharmaceuticals, Bone Defect Treatment, Stem Cell Therapy, Adipose Stem Cells, Clinical-Stage Biotechnology, Bone Injury Healing, Congenital Pseudarthrosis Of The Tibia, Autologous Therapy, Allogeneic Products, Bioactive Factors, Single-Treatment Solutions, Room Temperature Storage
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches NOVADIP Biosciences S.A. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at NOVADIP Biosciences S.A. on 11 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.